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Yang Yu1,2,3, Qian Gao1, Hong-cui Zhao1, Rong Li1,2,3, Jiang-man Gao1, Ting Ding1,3, Si-yu Bao1,2, Yue Zhao1,3,
Xiao-fang Sun4, Yong Fan1,4* and Jie Qiao1,2,3*Erratum
Following the publication of our article [1], we noticed
that some incorrect images had been incorporated into
figure twoB (included here as Fig. 1b) and threeF-H
(included here as Fig. 2f-h) in error. The corrected
figures are given below. This correction does not change
the results or conclusion of the original study.
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Fig. 2 Differentiation abilities of human parthenogenetic embryonic stem cells. In vitro differentiated EBs displayed (a) positive AFP staining (endoderm),
(b) positive SMA staining (mesoderm), (c) positive TUBULIN staining (ectoderm), and (d) expression of genes from endoderm (NF68KD), mesoderm (HBZ)
and ectoderm (Albumin). Bar is 50 μm. (e) Efficiency of teratoma formation upon injection of human parthenogenetic embryonic stem cells into SCID
mice; (f) neuro-ectoderm from ectoderm in teratoma; (g) cartilage from mesoderm in teratoma; (h) glandular tissue from endoderm in teratoma. Bar is
100 μm. EB, embryoid bodies; SCID, severe combined immunodeficiency
Fig. 1 Identification of human parthenogenetic embryonic stem cells. a Colony of human parthenogenetic embryonic stem cells; (b) positive staining
for alkaline phosphatase; (c) normal 46, XX karyotype at passage 20; (d) positive staining for OCT4; (e) positive staining for NANOG; (f) positive staining
for TRA-1-60; (D1-F1) nuclear staining with Hoechst 33342; (D2-F2) merged images for OCT4, NANOG and TRA-1-60. Bar is 100 μm
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